United Therapeutic (UTHR) 122.28 $UTHR
United Therapeutics Falls 2.03% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Aug 26, 2:01PM CDT
United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $119.70 to a high of $124.80. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $121.64 on volume of 266,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
UTHR: 122.28 (+0.37)
Look for Shares of United Therapeutics to Potentially Rebound after Yesterday's 2.03% Sell Off
Comtex SmarTrend(R) - Fri Aug 26, 2:00PM CDT
United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $119.70 to a high of $124.80. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $121.64 on volume of 266,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
UTHR: 122.28 (+0.37)
Drug Makers Stocks Under Scanner -- Amarin, Depomed, United Therapeutics, and Sucampo Pharma
PR Newswire - Tue Aug 16, 6:40AM CDT
In today's pre-market research, Stock-Callers.com follows four Drug Manufacturing equities, namely, Amarin Corp. PLC (NASDAQ: AMRN), Depomed Inc. (NASDAQ: DEPO), United Therapeutics Corp. (NASDAQ: UTHR), and Sucampo Pharmaceuticals Inc. (NASDAQ: SCMP). Global prescription drug sales are expected to increase 3% this year despite drug-price debates and cost-control pressures. You can access of our complimentary research reports on these stocks now at:
UTHR: 122.28 (+0.37), AMRN: 2.80 (+0.01), SCMP: 10.96 (-0.05), DEPO: 20.29 (+0.24)
Cempra Appoints Dr. David Zaccardelli to Board of Directors
GlobeNewswire - Thu Aug 11, 3:05PM CDT
Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced that the company has appointed David Zaccardelli, Pharm.D. to serve on the company's board of directors.
UTHR: 122.28 (+0.37), CEMP: 21.94 (+0.50)
United Therapeutics Corporation To Present At The 2016 Wedbush PacGrow Healthcare Conference
PR Newswire - Wed Aug 10, 5:00AM CDT
United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the 2016 Wedbush PacGrow Healthcare Conference in New York City.
UTHR: 122.28 (+0.37)
SmarTrend Watching for Potential Pullback in Shares of United Therapeutics After 3.53% Gain
Comtex SmarTrend(R) - Mon Aug 01, 2:37PM CDT
United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $121.01 to a high of $126.65. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $122.23 on volume of 483,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
UTHR: 122.28 (+0.37)
Watch for United Therapeutics to Potentially Pullback After Gaining 3.53% Yesterday
Comtex SmarTrend(R) - Mon Aug 01, 2:35PM CDT
United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $121.01 to a high of $126.65. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $122.23 on volume of 483,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
UTHR: 122.28 (+0.37)
SmarTrend Watching for Potential Pullback in Shares of United Therapeutics After 4.98% Gain
Comtex SmarTrend(R) - Thu Jul 28, 2:49PM CDT
United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $112.73 to a high of $118.98. Yesterday, the shares gained 5.0%, which took the trading range above the 3-day high of $114.12 on volume of 448,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
UTHR: 122.28 (+0.37)
Watch for United Therapeutics to Potentially Pullback After Gaining 4.98% Yesterday
Comtex SmarTrend(R) - Thu Jul 28, 2:47PM CDT
United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $112.73 to a high of $118.98. Yesterday, the shares gained 5.0%, which took the trading range above the 3-day high of $114.12 on volume of 448,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
UTHR: 122.28 (+0.37)
United Therapeutics Corporation Reports Second Quarter 2016 Financial Results
PR Newswire - Thu Jul 28, 5:00AM CDT
United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30, 2016.
UTHR: 122.28 (+0.37)
Nivalis (NVLS): Can the Stock Surprise This Earnings Season?
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 5:46PM CDT
Nivalis Therapeutics (NVLS), which is expected to report second-quarter 2016 results on Aug 1, posted a negative surprise of 15.91% last quarter.
VRTX: 94.51 (-1.29), NVLS: 6.39 (+0.08), UTHR: 122.28 (+0.37), BMY: 57.39 (+0.15)
Featured Research Report on Drug Manufacturers Stocks
ACCESSWIRE - Tue Jun 14, 8:15AM CDT
LONDON, UK / ACCESSWIRE / June 14, 2016 / ActiveWallSt.com announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Drug Manufacturers-Other industry. Companies recently under review include Ionis Pharma, Depomed, Amarin, and United Therapeutics. Register with us now for your free membership and see our complete reports on these equities at:
UTHR: 122.28 (+0.37), AMRN: 2.80 (+0.01), DEPO: 20.29 (+0.24), IONS: 29.65 (-0.04)
United Therapeutics Rises 1.86% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Jun 02, 2:47PM CDT
United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $118.58 to a high of $121.69. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $119.59 on volume of 230,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
UTHR: 122.28 (+0.37)
Downgrade Alert for United Therapeutics (UTHR)
Comtex SmarTrend(R) - Wed May 25, 3:38AM CDT
United Therapeutics (NASDAQ:UTHR) was downgraded from Buy to Hold at Argus Research today. The stock closed yesterday at $116.62 on volume of 639,000 shares, below average daily volume of 888,000. United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company's lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously. United's products are currently in Phase III clinical trials.
UTHR: 122.28 (+0.37)
United Therapeutics Partnering Deals and Alliances 2010 to 2016
PR Newswire - Tue May 24, 3:47PM CDT
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world's leading life sciences companies.
UTHR: 122.28 (+0.37)
Crosswind PR Issues Correction to May 9 Press Release
PRWeb - Tue May 10, 3:10PM CDT
Crosswind Media & PR issues the following correction to a press release issued May 9, 2016. The press release titled, "United Therapeutics Selects HCB Health as Agency of Record for Remodulin," was printed in error. This is now removed from online news sources and outlets. Crosswind Media & PR takes full responsibility for this error. This was not an error made by our client, HCB Health, nor the fault of PRWeb. Moreover, the press release was not reviewed or approved by United Therapeutics Corporation.
UTHR: 122.28 (+0.37)
3 Dirt-Cheap Biotech Stocks To Buy
Todd Campbell, The Motley Fool - Motley Fool - Wed May 04, 8:17AM CDT
SOURCE: FLICKR USER ELLIOTT BROWN Sometimes stocks sell down to prices that look too good to be true, but just because a company appears cheap doesn't mean that its a good value. For a company to be a bargain that's really worth buying, there needs...
ENDP: 20.70 (-0.19), GILD: 78.38 (+0.46), MRK: 62.79 (+0.08), UTHR: 122.28 (+0.37)
United (UTHR) Stock Declines Despite Q1 Earnings Beat
Arpita Dutt - Zacks Investment Research - Fri Apr 29, 10:54AM CDT
Although United Therapeutics (UTHR) delivered an earnings beat, shares were down on the revenue miss.
EBS: 26.65 (-0.41), UTHR: 122.28 (+0.37), AEGR: 1.63 (+0.01)
United Therapeutics Falls 2.03% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Aug 26, 2:01PM CDT
United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $119.70 to a high of $124.80. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $121.64 on volume of 266,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
UTHR: 122.28 (+0.37)
Look for Shares of United Therapeutics to Potentially Rebound after Yesterday's 2.03% Sell Off
Comtex SmarTrend(R) - Fri Aug 26, 2:00PM CDT
United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $119.70 to a high of $124.80. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $121.64 on volume of 266,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
UTHR: 122.28 (+0.37)
Drug Makers Stocks Under Scanner -- Amarin, Depomed, United Therapeutics, and Sucampo Pharma
PR Newswire - Tue Aug 16, 6:40AM CDT
In today's pre-market research, Stock-Callers.com follows four Drug Manufacturing equities, namely, Amarin Corp. PLC (NASDAQ: AMRN), Depomed Inc. (NASDAQ: DEPO), United Therapeutics Corp. (NASDAQ: UTHR), and Sucampo Pharmaceuticals Inc. (NASDAQ: SCMP). Global prescription drug sales are expected to increase 3% this year despite drug-price debates and cost-control pressures. You can access of our complimentary research reports on these stocks now at:
UTHR: 122.28 (+0.37), AMRN: 2.80 (+0.01), SCMP: 10.96 (-0.05), DEPO: 20.29 (+0.24)
Cempra Appoints Dr. David Zaccardelli to Board of Directors
GlobeNewswire - Thu Aug 11, 3:05PM CDT
Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced that the company has appointed David Zaccardelli, Pharm.D. to serve on the company's board of directors.
UTHR: 122.28 (+0.37), CEMP: 21.94 (+0.50)
United Therapeutics Corporation To Present At The 2016 Wedbush PacGrow Healthcare Conference
PR Newswire - Wed Aug 10, 5:00AM CDT
United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the 2016 Wedbush PacGrow Healthcare Conference in New York City.
UTHR: 122.28 (+0.37)
SmarTrend Watching for Potential Pullback in Shares of United Therapeutics After 3.53% Gain
Comtex SmarTrend(R) - Mon Aug 01, 2:37PM CDT
United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $121.01 to a high of $126.65. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $122.23 on volume of 483,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
UTHR: 122.28 (+0.37)
Watch for United Therapeutics to Potentially Pullback After Gaining 3.53% Yesterday
Comtex SmarTrend(R) - Mon Aug 01, 2:35PM CDT
United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $121.01 to a high of $126.65. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $122.23 on volume of 483,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
UTHR: 122.28 (+0.37)
SmarTrend Watching for Potential Pullback in Shares of United Therapeutics After 4.98% Gain
Comtex SmarTrend(R) - Thu Jul 28, 2:49PM CDT
United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $112.73 to a high of $118.98. Yesterday, the shares gained 5.0%, which took the trading range above the 3-day high of $114.12 on volume of 448,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
UTHR: 122.28 (+0.37)
Watch for United Therapeutics to Potentially Pullback After Gaining 4.98% Yesterday
Comtex SmarTrend(R) - Thu Jul 28, 2:47PM CDT
United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $112.73 to a high of $118.98. Yesterday, the shares gained 5.0%, which took the trading range above the 3-day high of $114.12 on volume of 448,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
UTHR: 122.28 (+0.37)
United Therapeutics Corporation Reports Second Quarter 2016 Financial Results
PR Newswire - Thu Jul 28, 5:00AM CDT
United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30, 2016.
UTHR: 122.28 (+0.37)
Nivalis (NVLS): Can the Stock Surprise This Earnings Season?
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 5:46PM CDT
Nivalis Therapeutics (NVLS), which is expected to report second-quarter 2016 results on Aug 1, posted a negative surprise of 15.91% last quarter.
VRTX: 94.51 (-1.29), NVLS: 6.39 (+0.08), UTHR: 122.28 (+0.37), BMY: 57.39 (+0.15)
Featured Research Report on Drug Manufacturers Stocks
ACCESSWIRE - Tue Jun 14, 8:15AM CDT
LONDON, UK / ACCESSWIRE / June 14, 2016 / ActiveWallSt.com announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Drug Manufacturers-Other industry. Companies recently under review include Ionis Pharma, Depomed, Amarin, and United Therapeutics. Register with us now for your free membership and see our complete reports on these equities at:
UTHR: 122.28 (+0.37), AMRN: 2.80 (+0.01), DEPO: 20.29 (+0.24), IONS: 29.65 (-0.04)
United Therapeutics Rises 1.86% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Jun 02, 2:47PM CDT
United Therapeutics (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $118.58 to a high of $121.69. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $119.59 on volume of 230,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
UTHR: 122.28 (+0.37)
Downgrade Alert for United Therapeutics (UTHR)
Comtex SmarTrend(R) - Wed May 25, 3:38AM CDT
United Therapeutics (NASDAQ:UTHR) was downgraded from Buy to Hold at Argus Research today. The stock closed yesterday at $116.62 on volume of 639,000 shares, below average daily volume of 888,000. United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company's lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously. United's products are currently in Phase III clinical trials.
UTHR: 122.28 (+0.37)
United Therapeutics Partnering Deals and Alliances 2010 to 2016
PR Newswire - Tue May 24, 3:47PM CDT
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world's leading life sciences companies.
UTHR: 122.28 (+0.37)
Crosswind PR Issues Correction to May 9 Press Release
PRWeb - Tue May 10, 3:10PM CDT
Crosswind Media & PR issues the following correction to a press release issued May 9, 2016. The press release titled, "United Therapeutics Selects HCB Health as Agency of Record for Remodulin," was printed in error. This is now removed from online news sources and outlets. Crosswind Media & PR takes full responsibility for this error. This was not an error made by our client, HCB Health, nor the fault of PRWeb. Moreover, the press release was not reviewed or approved by United Therapeutics Corporation.
UTHR: 122.28 (+0.37)
3 Dirt-Cheap Biotech Stocks To Buy
Todd Campbell, The Motley Fool - Motley Fool - Wed May 04, 8:17AM CDT
SOURCE: FLICKR USER ELLIOTT BROWN Sometimes stocks sell down to prices that look too good to be true, but just because a company appears cheap doesn't mean that its a good value. For a company to be a bargain that's really worth buying, there needs...
ENDP: 20.70 (-0.19), GILD: 78.38 (+0.46), MRK: 62.79 (+0.08), UTHR: 122.28 (+0.37)
United (UTHR) Stock Declines Despite Q1 Earnings Beat
Arpita Dutt - Zacks Investment Research - Fri Apr 29, 10:54AM CDT
Although United Therapeutics (UTHR) delivered an earnings beat, shares were down on the revenue miss.
EBS: 26.65 (-0.41), UTHR: 122.28 (+0.37), AEGR: 1.63 (+0.01)
